Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03732794 · ClinicalTrials.gov registry record · NA
AtriCure CryoICE Lesions for Persistent and Long-standing Persistent Atrial Fibrillation Treatment
A NA study of Atrial Fibrillation (AF) and Persistent Atrial Fibrillation, sponsored by AtriCure.
- Active
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 15
- Study locations
NCT03732794 is a NA study of Atrial Fibrillation (AF) and Persistent Atrial Fibrillation that is active but no longer recruiting, run by AtriCure. The registered enrollment target is 150 participants, below the 711-participant average among 17 other Atrial Fibrillation (AF) trials with a reported enrollment target (79% lower). The trial reports 15 study locations across 11 states.
The verdict
NCT03732794, a NA study of Atrial Fibrillation (AF) and Persistent Atrial Fibrillation, is active but no longer recruiting, sponsored by AtriCure.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 15
- Study locations
Study Summary
The primary objective of this study is to evaluate the safety and effectiveness of the AtriCure CryoICE system in performing the Cox-Maze III lesion set, in conjunction with Left Atrial Appendage (LAA) exclusion using the AtriClip device.
Conditions Studied
Interventions
- DEVICE AtriCure CryoICE & AtriClip LAA Exclusion
Study Locations (15)
New York
- Mount Sinai Icahn School of Medicine - New York
- NYP-Weill Cornell - New York
- Northwell Health Systems - New York
- St. Joseph Hospital Health Center - Syracuse
Indiana
- Franciscan Health - Indianapolis
- Deaconess Gateway Hospital - Newburgh
California
- UCLA Medical Center - Los Angeles
District of Columbia
- Washington Adventist Hospital - Washington D.C.
Illinois
- Northwestern Medicine - Chicago
Maryland
- University Of Maryland - Baltimore
Michigan
- University of Michigan - Ann Arbor
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2019-01-30 |
| Est. Completion | 2026-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03732794
The ClinicalTrials.gov registry entry for NCT03732794 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 711-participant average among 17 other Atrial Fibrillation (AF) trials with a reported enrollment target (79% lower). The listed sponsor is AtriCure, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Atrial Fibrillation (AF) appearing as the primary indexed condition, and to 1 intervention - of which AtriCure CryoICE & AtriClip LAA Exclusion is the first listed.
NCT03732794 reports 15 study locations spanning 11 distinct geographic areas - top geographies include New York, Indiana, California.
Frequently Asked Questions
What is clinical trial NCT03732794 about?
NCT03732794 is a clinical study titled "AtriCure CryoICE Lesions for Persistent and Long-standing Persistent Atrial Fibrillation Treatment". The primary objective of this study is to evaluate the safety and effectiveness of the AtriCure CryoICE system in performing the Cox-Maze III lesion set, in conjunction with Left Atrial Appendage (LAA) exclusion using the AtriClip device.
What is the current status of trial NCT03732794?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2019-01-30. Estimated completion is 2026-06.
What conditions does trial NCT03732794 study?
This clinical trial studies the following conditions: Atrial Fibrillation (AF), Persistent Atrial Fibrillation, Longstanding Persistent Atrial Fibrillation.
What interventions are being tested in trial NCT03732794?
The interventions under investigation include: AtriCure CryoICE & AtriClip LAA Exclusion (DEVICE).
Who is sponsoring clinical trial NCT03732794?
This trial is sponsored by AtriCure, which has 23 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03732794 being conducted?
This trial has 15 study locations across California, District of Columbia, Illinois, Indiana, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atrial Fibrillation (AF)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Digitally Rendered Interventions And Knowledge To Limit Ethanol-Associated Atrial Fibrillation Severity
RECRUITING · NA
-
Disrupted Sleep and Concurrent Ectopy or Atrial Fibrillation
RECRUITING · NA
-
Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure
RECRUITING · NA
-
Artificial Intelligence Mapping and Ablation of Non-Pulmonary Vein Electrical Drivers of AF Study
RECRUITING · NA
-
Full-Avoidance vs. Permissive/Regulated Drinking & Outcomes On Fibrillation
RECRUITING · NA
-
A Global Study Comparing Pulsed Field Ablation With Electrographic Flow Mapping Versus Posterior Wall Ablation for Persistent Atrial Fibrillation
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.